These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2825900)

  • 41. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solubilization of a functionally active platelet-activating factor receptor from rabbit platelets.
    Rogers JE; Duronio V; Wong SI; McNeil M; Salari H
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):405-10. PubMed ID: 1654881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro.
    Jones MA; Kudolo GB; Harper MJ
    Mol Reprod Dev; 1992 Jul; 32(3):243-50. PubMed ID: 1323306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis.
    Yang HO; Suh DY; Han BH
    Planta Med; 1995 Feb; 61(1):37-40. PubMed ID: 7700989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
    Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
    J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor.
    Shen TY; Hussaini IM
    Methods Enzymol; 1990; 187():446-54. PubMed ID: 2172742
    [No Abstract]   [Full Text] [Related]  

  • 50. Regulation of the receptor for platelet-activating factor on human platelets.
    Burgers JA; Akkerman JW
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):157-61. PubMed ID: 8385926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat.
    Dray F; Gerozissis K; Fafeur V; Wisner A; Bommelaer-Bayet MC; Saadi M; Rougeot C; Tiberghien C; Junier MP
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():383-6. PubMed ID: 2546391
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of platelet-activating factor in cardiovascular pathophysiology.
    Montrucchio G; Alloatti G; Camussi G
    Physiol Rev; 2000 Oct; 80(4):1669-99. PubMed ID: 11015622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Monte Carlo pharmacophore generation procedure: application to the human PAF receptor.
    Hodgkin EE; Miller A; Whittaker M
    J Comput Aided Mol Des; 1993 Oct; 7(5):515-34. PubMed ID: 8294944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet-activating factor: a novel lipid agonist.
    Hanahan DJ
    Curr Top Cell Regul; 1992; 33():65-78. PubMed ID: 1323447
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma.
    Stenzel H; Hümmer B; Hahn HL
    Agents Actions Suppl; 1987; 21():253-60. PubMed ID: 2823582
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of PAF-acether antagonists on active anaphylactic mouse paw edema.
    Amorim CZ; Henriques MG; Weg VB; Cordeiro RS; Vargaftig BB
    Lipids; 1991 Dec; 26(12):1396-9. PubMed ID: 1668123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
    Curtis LD
    Adv Exp Med Biol; 1996; 416():361-3. PubMed ID: 9131174
    [No Abstract]   [Full Text] [Related]  

  • 58. The continuing biochemical challenge of PAF and closely related lipid mediators.
    Hanahan DJ
    Adv Exp Med Biol; 1996; 416():1-3. PubMed ID: 9131117
    [No Abstract]   [Full Text] [Related]  

  • 59. A pharmacophore for high affinity PAF antagonists. II. Hydrophobicity study using the molecular lipophilicity potential.
    Le Solleu H; Laguerre M; Saux M; Dubost JP
    J Lipid Mediat Cell Signal; 1997 Jun; 16(2):75-113. PubMed ID: 9172050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin E2, leukotriene C4, and platelet-activating factor receptor sites in the brain. Binding parameters and pharmacological studies.
    Dray F; Wisner A; Bommelaer-Bayet MC; Tiberghien C; Gerozissis K; Saadi M; Junier MP; Rougeot C
    Ann N Y Acad Sci; 1989; 559():100-11. PubMed ID: 2549827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.